Author

Yang Liu

University of CopenhagenORCID 0000-0001-6208-7285Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yang Liu46 papers · BGI Group (China)

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Bauke de BoeriD· 1 shared Bo Torben PorseiD· 1 shared Erwin M. SchoofiD· 1 shared Jinyu SuiD· 1 shared Kim Theilgaard‐MönchiD· 1 shared Kirsten GrønbækiD· 1 shared Mikkel Bruhn SchusteriD· 1 shared Nanna S. MikkelseniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bauke de BoerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 20, 2026

Cholesterol Biosynthesis is a Targetable Vulnerability of CEBPA-mutant Acute Myeloid Leukemia

Sofie Ulfbeck Schovsbo, Yang Liu, Pedro Aragon-Fernandez…·Bo Torben Porse

This study identifies cholesterol biosynthesis as a therapeutic target in CEBPA-mutant AML, showing that statins enhance chemosensitivity in cells with co-mutations in TET2 or WT1.

DOI 10.64898/2026.02.20.706425

𝕏 PostBluesky